Alx Oncology Holdings reported net income of -$17.97M for the quarter ended Jun 2026. This income statement covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 40.49M | 40.59M | 40.66M | 40.75M | 40.75M | 40.86M | 40.86M | 40.99M | 41.15M | 49.95M | 50.28M | 52.45M | 52.74M | 53.05M | 53.38M | 53.51M | 53.58M | 54.39M | 104.57M | 138.22M | |||||||||
| Revenue & cost | |||||||||||||||||||||||||||||
| Revenue | |||||||||||||||||||||||||||||
| Operating items | |||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 18.21M | 20.89M | 17.07M | 26.75M | 29.38M | 25.20M | 24.76M | 29.48M | 45.77M | 41.78M | 31.72M | 34.65M | 26.47M | 23.53M | 23.89M | 18.02M | 17.44M | 17.64M | 13.61M | 13.14M | |||||||||
| Selling, General & AdministrativeSG&A | 6.36M | 7.58M | 7.67M | 7.04M | 7.30M | 7.02M | 7.44M | 7.29M | 7.51M | 6.24M | 6.04M | 6.87M | 6.10M | 7.08M | 7.93M | 5.45M | 5.09M | 5.38M | 5.36M | 5.13M | |||||||||
| Restructuring CostsRestructuring | 2.28M | 1.87M | |||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 0.90M | -2.11M | |||||||||||||||||||||||||||
| Operating ExpensesOpex | 24.58M | 28.47M | 24.75M | 33.79M | 36.68M | 32.22M | 32.20M | 36.78M | 53.27M | 48.02M | 37.76M | 41.52M | 32.57M | 30.61M | 31.82M | 26.65M | 22.53M | 23.02M | 18.97M | 18.03M | |||||||||
| Operating IncomeOp. Inc | -24.58M | -28.47M | -24.75M | -33.79M | -36.68M | -32.22M | -32.20M | -36.78M | -53.27M | -48.02M | -37.76M | -41.52M | -32.57M | -30.61M | -31.82M | -26.65M | -22.53M | -23.02M | -18.97M | -18.03M | |||||||||
| EBIT | -24.58M | -28.47M | -24.75M | -33.79M | -36.68M | -32.22M | -32.20M | -36.78M | -53.27M | -48.02M | -37.76M | -41.52M | -32.57M | -30.61M | -31.82M | -26.65M | -22.53M | -23.02M | -18.97M | -18.03M | |||||||||
| Non-operating items | |||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.00M | 0.00M | 0.00M | 0.23M | 0.39M | 0.37M | 0.39M | 0.41M | 0.43M | 0.43M | 0.45M | 0.43M | 0.41M | 0.41M | 0.41M | 0.38M | 0.33M | 0.28M | |||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | 0.02M | -0.61M | -0.65M | 1.37M | 1.81M | 0.76M | -0.22M | 2.68M | 3.00M | -0.23M | -0.10M | 2.30M | 1.88M | -0.16M | 1.11M | 0.80M | 0.57M | -0.27M | 1.51M | |||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.01M | 11.04M | -0.01M | -0.01M | -0.01M | 18.97M | 0.10M | 0.32M | -0.00M | 6.64M | -0.01M | -0.01M | 0.00M | 4.69M | -0.01M | -0.00M | -0.01M | 2.46M | 0.19M | -0.90M | |||||||||
| Net income details | |||||||||||||||||||||||||||||
| EBT | -24.57M | -28.46M | -25.36M | -34.44M | -35.31M | -30.64M | -31.83M | -37.37M | -50.99M | -45.44M | -38.42M | -42.05M | -30.71M | -29.16M | -32.38M | -25.95M | -22.14M | -22.83M | -19.57M | -16.81M | |||||||||
| Tax ProvisionsTaxes | |||||||||||||||||||||||||||||
| Profit After TaxPAT | -24.57M | -28.44M | -24.53M | -32.92M | -35.57M | -29.20M | -30.18M | -34.16M | -50.99M | -45.47M | -35.58M | -39.40M | -30.71M | -29.16M | -30.75M | -26.03M | -22.14M | -22.62M | -17.93M | -17.97M | |||||||||
| Income from Continuing OperationsIncome (Continuing) | -24.57M | -28.46M | -25.36M | -34.44M | -35.31M | -30.64M | -31.83M | -37.37M | -50.99M | -45.44M | -38.42M | -42.05M | -30.71M | -29.16M | -32.38M | -25.95M | -22.14M | -22.83M | -19.57M | -16.81M | |||||||||
| Consolidated Net IncomeConsol Net Inc. | -24.57M | -28.46M | -25.36M | -34.44M | -35.31M | -30.64M | -31.83M | -37.37M | -50.99M | -45.44M | -38.42M | -42.05M | -30.71M | -29.16M | -32.38M | -25.95M | -22.14M | -22.83M | -19.57M | -16.81M | |||||||||
| Income towards Parent CompanyParent Net Inc | -24.57M | -28.46M | -25.36M | -34.44M | -35.31M | -30.64M | -31.83M | -37.37M | -50.99M | -45.44M | -38.42M | -42.05M | -30.71M | -29.16M | -32.38M | -25.95M | -22.14M | -22.83M | -19.57M | -16.81M | |||||||||
| Preferred Dividend PaymentsPref Dividends | |||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -24.57M | -28.44M | -25.36M | -34.44M | -35.31M | -30.64M | -31.83M | -37.37M | -50.99M | -45.44M | -38.42M | -42.05M | -30.71M | -29.16M | -32.38M | -25.95M | -22.14M | -22.83M | -19.57M | -16.81M | |||||||||
| Additional items | |||||||||||||||||||||||||||||
| EPS (Basic) | -0.61 | -0.71 | -0.62 | -0.85 | -0.87 | -0.75 | -0.78 | -0.91 | -1.24 | -1.06 | -0.77 | -0.81 | -0.58 | -0.56 | -0.61 | -0.49 | -0.41 | -0.43 | -0.19 | -0.12 | |||||||||
| EPS (Diluted) | -0.61 | -0.71 | -0.62 | -0.85 | -0.87 | -0.75 | -0.78 | -0.91 | -1.24 | -1.06 | -0.77 | -0.81 | -0.58 | -0.56 | -0.61 | -0.49 | -0.41 | -0.43 | -0.19 | -0.12 | |||||||||
| Shares Outstanding | 40.40M | 40.31M | 40.62M | 40.69M | 40.75M | 40.70M | 40.86M | 40.88M | 41.15M | 42.99M | 50.12M | 51.83M | 52.69M | 52.17M | 53.36M | 53.45M | 53.58M | 53.66M | 104.57M | 135.64M | |||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 40.40M | 40.31M | 40.62M | 40.69M | 40.75M | 40.70M | 40.86M | 40.88M | 41.15M | 42.99M | 50.12M | 51.83M | 52.69M | 52.17M | 53.36M | 53.45M | 53.58M | 53.66M | 104.57M | 135.64M | |||||||||
| EBITDA | -24.58M | -28.47M | -24.75M | -33.79M | -36.68M | -32.22M | -32.20M | -36.78M | -53.27M | -48.02M | -37.76M | -41.52M | -32.57M | -30.61M | -31.82M | -26.65M | -22.53M | -23.02M | -18.97M | -18.03M | |||||||||
| Interest ExpensesInt Expense | 0.00M | 0.00M | 0.00M | 0.23M | 0.39M | 0.37M | 0.39M | 0.41M | 0.43M | 0.43M | 0.45M | 0.43M | 0.41M | 0.41M | 0.41M | 0.38M | 0.33M | 0.28M | |||||||||||
| Tax Rate |